Scalp cooling cap may help patients undergoing chemotherapy keep hair
February 25th, 2011 - 1:28 pm ICT by ANIWashington, Feb 25 (ANI): Wake Forest University Baptist Medical Center will conduct a feasibility study to test the use of a scalp cooling device that breast cancer patients will wear while undergoing chemotherapy treatment.
This will be part of the first significant study of the medical device in the United States.
The FDA has given approval for an investigational device exemption (IDE) feasibility study to be conducted at both Wake Forest Baptist and University of California, San Francisco (UCSF). A total of 20 patients with stage one breast cancer will be involved - 10 at Wake Forest Baptist and 10 at UCSF. The study will test the safety and tolerability of the patented DigniCap scalp cooling system, which is worn by patients during chemotherapy treatment to prevent hair loss.
Susan Melin, principal investigator for the study, said data from several large international studies involving almost 1,000 chemotherapy patients indicate the device is safe to use and does prevent hair loss.
“Preventing chemotherapy-induced hair loss by using the scalp cooling cap may relieve severe psychological and emotional stress and improve the patient’s quality of life,” Melin said
The DigniCap system, developed by the Swedish company Dignitana, features a tight-fitting silicone cap that is placed directly on the head and an outer neoprene cap that insulates and secures the inner one. The cap is connected to a cooling and control unit with touch screen controls. A coolant circulates throughout the inner silicone layer, and the cap is designed to deliver consistent cooling to all areas of the scalp. The device features safety sensors that continuously monitor and optimize the treatment temperature.
When a cap is applied to the head, the temperature of the scalp is lowered and blood vessels surrounding the hair roots contract, resulting in a significant reduction of cytotoxins to the follicle. Reduced blood flow leaves a smaller amount of chemotherapy available for uptake in the cells, and the decreased temperature results in less absorption of and reduced effects from chemotherapy. These factors together reduce the risk of hair loss. (ANI)
- DigniCap may help cancer patients undergoing chemo keep hair - Dec 22, 2010
- Cold caps help cancer patients keep their hair - Dec 21, 2010
- Arsenic could improve survival for leukaemia patients - Nov 12, 2010
- Implantable artificial kidney set to make dialysis history - Sep 03, 2010
- Polypill 'a viable treatment option for patients at high risk of CVD' - Mar 22, 2011
- Electric shocks soften up cancer cells for treatment - Dec 07, 2010
- Over an hour of meditation reduces pain - Apr 06, 2011
- Blame constipation for bedwetting woes - Jan 30, 2012
- New procedure busts deadly brain tumour cells - Feb 06, 2012
- Excessive protein in scalp linked to male baldness - Apr 01, 2012
- Lab-grown urinary tubes implanted successfully - Mar 09, 2011
- Coming soon: Cloned hair follicles to cure baldness! - May 01, 2011
- How meditation reduces pain - Apr 06, 2011
- Acne is more than a nuisance for some adolescents - Mar 16, 2011
- Malaysian society committed to fighting hair loss gains popularity! - May 23, 2010
Tags: baptist medical center, breast cancer, breast cancer patients, california san francisco, chemotherapy patients, device features, emotional stress, feasibility study, forest university baptist medical, hair roots, investigational device exemption, melin, scalp cooling system, stage one, swedish company, treatment temperature, university baptist medical center, university of california san francisco, wake forest university, wake forest university baptist medical center